Centogene N.V.

Centogene N.V. is a clinical-stage biopharmaceutical company focused on transforming clinical, genetic, and proprietary multi-omic data into actionable information for patients with rare genetic diseases. The company operates an innovative platform for diagnosing and analyzing hereditary disorders, offering comprehensive genetic testing services that aid in the better understanding of these conditions. By leveraging a diverse biobank comprising numerous patient samples, Centogene plays a crucial role in the research and development of therapies and medications targeting rare diseases. Furthermore, the company collaborates with pharmaceutical companies to provide valuable insights and data that facilitate the discovery of new treatments and precision medicine applications. With headquarters in Rostock, Germany, Centogene's work significantly impacts the biopharmaceutical sector by advancing therapeutic research and fostering scientific knowledge about rare genetic conditions.